6550--MPLS - Toxicology Drugs of Abuse Supplies Reagents, Calibrators, and Controls for Assays - Solicitation
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 36C26325Q0057
- Agency
-
Veterans Integrated Service Network 23
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs, Veterans Health Administration, Veterans Integrated Service Network 23 is issuing a solicitation for a brand name only acquisition of FDA-approved CEDIA and DRI drugs of abuse reagents, calibrators, and controls for Oxycodone, Ecstasy, Heroin (6MAM), and Hydrocodone assays manufactured by Microgenics Corporation. This is a five-year, firm-fixed price, indefinite delivery/indefinite quantity contract for the Minneapolis VA Medical Center Toxicology Laboratory, which is the sole national provider of pre-employment and random employee drug testing for all VA Hospitals and their affiliated CBOCs. Offers must be submitted by November 21, 2024, and the base period of performance is December 8, 2024 to September 30, 2025, with four one-year option periods. The solicitation includes detailed information on delivery requirements, product quality standards, ordering procedures, and technical support.
This procurement is not set-aside. The required reagents and controls are manufactured solely by Microgenics Corporation, making this a brand name only requirement. Market research confirmed Microgenics and Fisher Scientific as the only authorized distributors. The estimated contract value is between $500,000 and $1,000,000. The Minneapolis VA Medical Center Toxicology Laboratory is certified by HHS SAMHSA to conduct the Federal Workplace Urine Drugs of Abuse Testing Program.
Notice text
BRAND NAME ONLY acquisition for FDA-approved CEDIA and DRI drugs of abuse reagents, calibrators, and controls for Oxycodone, Ecstasy, Heroin (6MAM), and Hydrocodone assays manufactured by Microgenics Corporation.
Files
| File | Type | Posted |
|---|---|---|
| P03 - Brand Name Only Justification - Redacted.docx | DOCX document | |
| 36C26325Q0057.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6550--MPLS - Toxicology Drugs of Abuse Supplies Reagents, Calibrators, and Controls for Assays | Award Notice | |
| This notice | Solicitation | |
| 6550--MPLS - Toxicology Drugs of Abuse Supplies Reagents, Calibrators, and Controls for Assays - Solicitation | Pre-Solicitation |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity